Shuji Ogino

Shuji Ogino's AcademicInfluence.com Rankings

Shuji Ogino

Medical

#1642

World Rank

#2005

Historical Rank

Epidemiology

#250

World Rank

#267

Historical Rank

medical Degrees

Shuji Ogino

Philosophy

#4993

World Rank

#7689

Historical Rank

Logic

#2343

World Rank

#3318

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Shuji Ogino's Degrees

Doctorate Medicine Kyoto University

Why Is Shuji Ogino Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Shuji Ogino's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion (2012) (1516)
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. (2012) (1492)
Long-term colorectal-cancer incidence and mortality after lower endoscopy. (2013) (1193)
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours (2013) (1136)
Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel (2012) (819)
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer (2017) (779)
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. (2012) (776)
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer (2008) (766)
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. (2007) (745)
Cancer classification using the Immunoscore: a worldwide task force (2012) (719)
Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity (2013) (700)
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity (2008) (630)
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis (2015) (616)
The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth (2008) (606)
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. (2005) (508)
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum (2012) (504)
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field (2010) (481)
Restriction of intestinal stem cell expansion and the regenerative response by YAP (2012) (474)
Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review (2010) (460)
Molecular classification and correlates in colorectal cancer. (2008) (438)
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. (2015) (423)
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma (2016) (396)
Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. (2013) (388)
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. (2006) (386)
Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype (2009) (383)
RNF43 is frequently mutated in colorectal and endometrial cancers (2014) (371)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer (2009) (365)
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. (2007) (354)
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma (2016) (353)
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies (2006) (352)
A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. (2008) (348)
Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development (2014) (333)
PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. (2009) (325)
Genetic Mechanisms of Immune Evasion in Colorectal Cancer. (2018) (305)
Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample (2008) (303)
CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. (2006) (302)
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer (2009) (302)
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion (2011) (298)
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors (2013) (282)
Discovery of common and rare genetic risk variants for colorectal cancer (2018) (279)
Cancer immunology—analysis of host and tumor factors for personalized medicine (2011) (274)
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. (2012) (260)
Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803 (2011) (258)
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer. (2016) (254)
HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. (2010) (253)
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component (2006) (250)
LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer (2008) (248)
Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes (2011) (248)
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. (2011) (248)
Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women (2019) (247)
Physical activity and male colorectal cancer survival. (2009) (245)
PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. (2008) (239)
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review (2012) (237)
Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers (2012) (224)
Colorectal cancer: a tale of two sides or a continuum? (2012) (217)
Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue (2017) (212)
Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location (2016) (211)
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease (2013) (203)
Statistical methods for studying disease subtype heterogeneity (2016) (199)
KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803 (2009) (194)
Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer (2008) (186)
Aspirin use and survival after diagnosis of colorectal cancer. (2009) (186)
NRAS Mutations Are Rare in Colorectal Cancer (2010) (175)
Villous capillary lesions of the placenta: distinctions between chorangioma, chorangiomatosis, and chorangiosis. (2000) (174)
Tumor microenvironment induces innate RAF-inhibitor resistance through HGF secretion (2012) (172)
Cohort study of fatty acid synthase expression and patient survival in colon cancer. (2008) (168)
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. (2014) (167)
Rising incidence of early-onset colorectal cancer — a call to action (2020) (167)
STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers (2011) (165)
Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology. (2012) (165)
Tumour CD274 (PD-L1) expression and T cells in colorectal cancer (2016) (165)
Aspirin use and risk of colorectal cancer according to BRAF mutation status. (2013) (164)
Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression (2015) (164)
Genetic risk assessment in carrier testing for spinal muscular atrophy. (2002) (163)
Genetic testing and risk assessment for spinal muscular atrophy (SMA) (2002) (163)
Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer (2005) (162)
Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. (2011) (162)
How many molecular subtypes? Implications of the unique tumor principle in personalized medicine (2012) (161)
Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. (2010) (161)
Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer (2009) (156)
Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology. (2019) (155)
A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. (2009) (154)
Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. (2009) (150)
Genotype and haplotype distributions of MTHFR 677C>T and 1298A>C single nucleotide polymorphisms: a meta-analysis (2003) (148)
Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer (2009) (148)
Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. (2013) (144)
Spinal muscular atrophy: molecular genetics and diagnostics (2004) (143)
The isopeptidase USP2a protects human prostate cancer from apoptosis. (2006) (141)
Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine (2016) (140)
Long-term use of antibiotics and risk of colorectal adenoma (2017) (139)
Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors (2010) (138)
Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. (2010) (138)
A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. (2009) (134)
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer (2018) (134)
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine (2018) (134)
DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer (2009) (131)
The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer. (2009) (129)
Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review (2011) (128)
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth. (2014) (125)
Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. (2015) (125)
Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. (2009) (125)
Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. (2007) (124)
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma (2007) (124)
A model to determine colorectal cancer risk using common genetic susceptibility loci. (2015) (121)
Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps. (2020) (120)
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review (2014) (120)
Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. (2011) (120)
New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations (2004) (118)
Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. (2017) (116)
Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling. (2012) (115)
Clinical laboratory reports in molecular pathology. (2007) (115)
Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology (2014) (115)
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial (2018) (114)
Association Between Risk Factors for Colorectal Cancer and Risk of Serrated Polyps and Conventional Adenomas. (2018) (113)
DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer (2010) (112)
Association of Dietary Inflammatory Potential With Colorectal Cancer Risk in Men and Women (2018) (110)
Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer (2007) (110)
Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. (2009) (110)
Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence (2016) (109)
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. (2013) (109)
Spatially organized multicellular immune hubs in human colorectal cancer (2021) (109)
Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. (2017) (108)
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of 15-Hydroxyprostaglandin Dehydrogenase (HPGD) (2014) (107)
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy. (2014) (106)
SIRT1 Histone Deacetylase Expression Is Associated with Microsatellite Instability and CpG Island Methylator Phenotype in Colorectal Cancer (2009) (106)
Erratum: Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma (Cell Reports (2016) 15(4) (857–865) (S2211124716303643) (10.1016/j.celrep.2016.03.075)) (2016) (106)
The urgent need for integrated science to fight COVID-19 pandemic and beyond (2020) (106)
CDK8 expression in 470 colorectal cancers in relation to β‐catenin activation, other molecular alterations and patient survival (2010) (104)
Prediagnostic body mass index and pancreatic cancer survival. (2013) (104)
Fiber Intake and Survival After Colorectal Cancer Diagnosis (2018) (103)
Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status (2018) (103)
Processed and Unprocessed Red Meat and Risk of Colorectal Cancer: Analysis by Tumor Location and Modification by Time (2015) (103)
Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes. (2017) (102)
MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. (2007) (101)
Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis. (2016) (100)
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma (2017) (100)
Correlation of Pathologic Features With CpG Island Methylator Phenotype (CIMP) by Quantitative DNA Methylation Analysis in Colorectal Carcinoma (2006) (100)
Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers (2011) (96)
Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer. (2007) (94)
Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis (2017) (93)
Prognostic significance of MTOR pathway component expression in neuroendocrine tumors. (2013) (93)
Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer. (2006) (92)
Sedentary Behaviors, TV Viewing Time, and Risk of Young-Onset Colorectal Cancer (2018) (92)
LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans (2015) (92)
Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. (2015) (91)
Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status (2015) (89)
Integration of molecular pathology, epidemiology and social science for global precision medicine (2016) (87)
The merits of subtyping obesity: one size does not fit all. (2013) (85)
A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. (2013) (84)
DNA methylation, field effects, and colorectal cancer. (2005) (84)
Prognostic Significance and Molecular Features of Signet-Ring Cell and Mucinous Components in Colorectal Carcinoma (2015) (84)
Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis. (2010) (84)
Prognostic Significance and Molecular Associations of Tumor Growth Pattern in Colorectal Cancer (2012) (83)
Dietary intake of fish, ω‐3 and ω‐6 fatty acids and risk of colorectal cancer: A prospective study in U.S. men and women (2014) (83)
Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum (2018) (82)
Periodontal disease, tooth loss and colorectal cancer risk: Results from the Nurses' Health Study (2017) (82)
Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. (2013) (81)
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer (2017) (80)
Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts12 (2015) (78)
Down‐regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer (2006) (77)
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. (2011) (77)
CDK 8 is a colorectal cancer oncogene that regulates b-catenin activity (2008) (77)
Physical activity and the risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 related mortality in South Korea: a nationwide cohort study (2021) (76)
Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors (2016) (76)
Cigarette Smoking and Pancreatic Cancer Survival. (2017) (76)
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers (2011) (75)
Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer (2010) (74)
Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas. (2020) (74)
Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. (2020) (74)
Malignant Rhabdoid Tumor: A Phenotype? An Entity?—A Controversy Revisited (2000) (74)
Inherited DNA Repair Defects in Colorectal Cancer (2018) (73)
A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer. (2014) (72)
A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases (2009) (72)
Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer. (2012) (72)
Interaction of Molecular Markers and Physical Activity on Mortality in Patients with Colon Cancer (2009) (72)
Post Diagnosis Diet Quality and Colorectal Cancer Survival in Women (2013) (71)
Meta‐analysis of 16 studies of the association of alcohol with colorectal cancer (2020) (71)
Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. (2013) (70)
Negative Lymph Node Count Is Associated With Survival of Colorectal Cancer Patients, Independent of Tumoral Molecular Alterations and Lymphocytic Reaction (2010) (70)
Association Between Sulfur-Metabolizing Bacterial Communities in Stool and Risk of Distal Colorectal Cancer in Men. (2020) (70)
CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci (2008) (69)
Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation (2016) (69)
Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. (2015) (69)
Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. (2012) (68)
Marine ω-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis (2016) (68)
Plasma Adiponectin and Soluble Leptin Receptor and Risk of Colorectal Cancer: A Prospective Study (2013) (68)
Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance) (2014) (67)
Early Life Body Fatness and Risk of Colorectal Cancer in U.S. Women and Men—Results from Two Large Cohort Studies (2015) (67)
Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome‐driven neoplasms (2019) (67)
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival (2017) (67)
Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis (2019) (67)
JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. (2009) (66)
Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. (2007) (66)
Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses (2019) (66)
Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk (2015) (65)
Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP (2007) (65)
Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis (2016) (65)
p21 Expression in Colon Cancer and Modifying Effects of Patient Age and Body Mass Index on Prognosis (2009) (64)
A prospective study of plasma inflammatory markers and risk of colorectal cancer in men (2013) (64)
Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. (2012) (64)
Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. (2013) (64)
Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. (2013) (63)
Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells. (2016) (63)
Vitamin D Receptor Expression Is Associated with PIK3CA and KRAS Mutations in Colorectal Cancer (2009) (62)
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance (2018) (61)
Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. (2008) (61)
Statin Use and Colorectal Cancer Risk According to Molecular Subtypes in Two Large Prospective Cohort Studies (2011) (60)
Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism. (2018) (59)
Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis. (2014) (58)
Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1 (2003) (57)
Tumor TP53 expression status, body mass index and prognosis in colorectal cancer (2012) (57)
DNA degradation test predicts success in whole-genome amplification from diverse clinical samples. (2007) (56)
Progress and Opportunities in Molecular Pathological Epidemiology of Colorectal Premalignant Lesions (2014) (56)
PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer (2017) (56)
Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor. (2017) (55)
An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer (2013) (55)
Cathepsin B Expression and Survival in Colon Cancer: Implications for Molecular Detection of Neoplasia (2010) (55)
Anatomic subsite of primary colorectal cancer and subsequent risk and distribution of second cancers (2013) (55)
Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women (2021) (55)
TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. (2007) (54)
Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). (2015) (54)
Characterization of the Neuroendocrine Tumor Immune Microenvironment (2018) (54)
18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high (2007) (54)
The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms. (2017) (54)
Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes. (2016) (54)
WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer (2008) (53)
Calcium intake and colorectal cancer risk: Results from the nurses' health study and health professionals follow‐up study (2016) (53)
Dietary patterns during high school and risk of colorectal adenoma in a cohort of middle‐aged women (2014) (52)
A Cohort Study of STMN1 Expression in Colorectal Cancer: Body Mass Index and Prognosis (2009) (51)
Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum. (2020) (51)
TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas (2018) (51)
The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment (2020) (51)
CpG methylation analysis--current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology. (2009) (50)
A Cohort Study of p27 Localization in Colon Cancer, Body Mass Index, and Patient Survival (2009) (50)
Mendelian randomization study of height and risk of colorectal cancer. (2015) (50)
Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype (2008) (49)
MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival (2016) (49)
Utility of inverse probability weighting in molecular pathological epidemiology (2018) (49)
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study (2020) (49)
Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts (2018) (49)
A Prospective Study of Dietary Folate and Vitamin B and Colon Cancer According to Microsatellite Instability and KRAS Mutational Status (2008) (49)
Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. (2013) (48)
B Vitamins, Methionine and Alcohol Intake and Risk of Colon Cancer in Relation to BRAF Mutation and CpG Island Methylator Phenotype (CIMP) (2011) (48)
The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma (2011) (47)
Immunoscore for (colorectal) cancer precision medicine (2018) (47)
TGFBR2 and BAX Mononucleotide Tract Mutations, Microsatellite Instability, and Prognosis in 1072 Colorectal Cancers (2011) (47)
Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality. (2017) (46)
Proceedings of the second international molecular pathological epidemiology (MPE) meeting (2015) (45)
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair–Deficient Colorectal Cancer (2019) (45)
Long-term status and change of body fat distribution, and risk of colorectal cancer: a prospective cohort study. (2015) (45)
Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance) (2018) (45)
Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance) (2018) (44)
MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer (2016) (44)
Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate (2016) (44)
Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer. (2020) (43)
Optical Imaging with a Cathepsin B Activated Probe for the Enhanced Detection of Esophageal Adenocarcinoma by Dual Channel Fluorescent Upper GI Endoscopy (2012) (42)
The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome. (2018) (42)
A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses’ Health Study (2017) (42)
Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer. (2012) (42)
Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance) (2017) (41)
Marine ω-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability. (2015) (41)
Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis (2006) (41)
Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study (2016) (41)
Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies. (2012) (40)
IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53. (2007) (40)
Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality. (2015) (40)
Urinary PGE-M Levels Are Associated with Risk of Colorectal Adenomas and Chemopreventive Response to Anti-Inflammatory Drugs (2014) (39)
Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer (2013) (39)
Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer (2010) (39)
Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival (2020) (38)
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer (2020) (38)
Spinal muscular atrophy genetic testing experience at an academic medical center. (2002) (38)
Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer (2017) (38)
Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. (2016) (37)
A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers. (2015) (36)
Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer. (2010) (36)
Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. (2018) (36)
The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer. (2007) (36)
A prospective study of bisphosphonate use and risk of colorectal cancer. (2012) (35)
Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas (2019) (35)
Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status. (2016) (35)
Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. (2016) (35)
Red Meat Intake, NAT2, and Risk of Colorectal Cancer: A Pooled Analysis of 11 Studies (2014) (35)
Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival (2016) (34)
No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections. (2012) (34)
Molecular pathological epidemiology gives clues to paradoxical findings (2015) (34)
Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer? (2017) (34)
Statin use and pancreatic cancer risk in two prospective cohort studies (2018) (34)
Comparative Immunohistochemical Study of Insulin-like Growth Factor II and Insulin-like Growth Factor ReceptorType 1 in Pediatric Brain Tumors (2001) (34)
Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma (2008) (33)
PTGER2 Overexpression in Colorectal Cancer Is Associated with Microsatellite Instability, Independent of CpG Island Methylator Phenotype (2010) (33)
MicroRNA MIR21 and T Cells in Colorectal Cancer (2015) (32)
Dietary intake of fiber, whole grains and risk of colorectal cancer: An updated analysis according to food sources, tumor location and molecular subtypes in two large US cohorts (2019) (31)
Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR) (2017) (31)
The role of epidemiology in the era of molecular epidemiology and genomics: Summary of the 2013 AJE-sponsored Society of Epidemiologic Research Symposium. (2013) (31)
Inflammatory Plasma Markers and Pancreatic Cancer Risk: A Prospective Study of Five U.S. Cohorts (2013) (30)
Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer (2016) (30)
Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. (2016) (30)
Adulthood Weight Change and Risk of Colorectal Cancer in the Nurses' Health Study and Health Professionals Follow-up Study (2015) (30)
Atypical teratoid/rhabdoid tumor of the CNS: cytopathology and immunohistochemistry of insulin-like growth factor-II, insulin-like growth factor receptor type 1, cathepsin D, and Ki-67. (1999) (29)
Expression Profiling of Archival Tumors for Long-term Health Studies (2012) (29)
Bayesian analysis and risk assessment in genetic counseling and testing. (2004) (29)
Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology. (2018) (28)
Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region. (2014) (28)
Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab (2014) (28)
Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. (2015) (28)
Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells (2018) (28)
Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After the COVID-19 Pandemic (2020) (28)
Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principle. (2012) (27)
Opinion: Standardizing gene product nomenclature—a call to action (2021) (27)
Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathology. (2011) (27)
Predicted 25(OH)D Score and Colorectal Cancer Risk According to Vitamin D Receptor Expression (2014) (26)
Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women (2015) (26)
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses (2020) (26)
Is early-onset cancer an emerging global epidemic? Current evidence and future implications (2022) (26)
Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype. (2007) (26)
Quantification of PCR bias caused by a single nucleotide polymorphism in SMN gene dosage analysis. (2002) (26)
Simple sugar and sugar-sweetened beverage intake during adolescence and risk of colorectal cancer precursors: Adolescent sugar intake and colorectal polyp. (2021) (26)
Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies. (2020) (26)
Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer (2020) (25)
Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression. (2012) (25)
Aspirin Use and Risk of Colorectal Cancer Among Older Adults. (2021) (25)
Genome-Wide Interaction Analyses between Genetic Variants and Alcohol Consumption and Smoking for Risk of Colorectal Cancer (2016) (24)
Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin–Stained Sections (2020) (24)
Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer (2016) (24)
SMO Expression in Colorectal Cancer: Associations with Clinical, Pathological, and Molecular Features (2014) (24)
Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment (2021) (23)
Mendelian randomization analysis of C-reactive protein on colorectal cancer risk. (2018) (23)
Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer (2019) (23)
The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor–immune–microbiome interaction (2020) (23)
Soluble tumour necrosis factor receptor type II and survival in colorectal cancer (2016) (22)
Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival. (2013) (22)
An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer (2020) (22)
Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer (2020) (22)
A Prospective Analysis of Meat Mutagens and Colorectal Cancer in the Nurses’ Health Study and Health Professionals Follow-up Study (2016) (22)
DNA Methylation in the Rectal Mucosa Is Associated with Crypt Proliferation and Fecal Short-Chain Fatty Acids (2011) (21)
Genetic architectures of proximal and distal colorectal cancer are partly distinct (2020) (21)
Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis (2018) (21)
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer (2007) (21)
Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer (2015) (21)
Consumption of Fish and ω-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies. (2020) (21)
THERAPEUTIC DRUG MONITORING OF MYCOPHENOLIC ACID IN RENAL TRANSPLANT RECIPIENTS (2004) (21)
Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation (2004) (21)
Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance) (2018) (20)
Yogurt consumption and risk of conventional and serrated precursors of colorectal cancer (2019) (20)
SMN dosage analysis and risk assessment for spinal muscular atrophy. (2002) (20)
Total vitamin D intake and risks of early-onset colorectal cancer and precursors. (2021) (20)
Relationship of CDX 2 Loss with Molecular Features and Prognosis in Colorectal Cancer (2009) (20)
Genetic variants of adiponectin and risk of colorectal cancer (2014) (20)
Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells (2017) (19)
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk (2016) (19)
Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer (2018) (19)
Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors (2013) (18)
Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status (2017) (18)
Discovery and Features of an Alkylating Signature in Colorectal Cancer (2021) (18)
Renovascular reconstruction of grafts with renal artery variations in living kidney transplantation. (2005) (18)
PIK3CA mutation and colorectal cancer precision medicine (2017) (18)
Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies (2017) (18)
Effect of Supplementation With Marine ω-3 Fatty Acid on Risk of Colorectal Adenomas and Serrated Polyps in the US General Population: A Prespecified Ancillary Study of a Randomized Clinical Trial. (2019) (17)
Low-Carbohydrate Diet Score and Macronutrient Intake in Relation to Survival After Colorectal Cancer Diagnosis (2018) (17)
Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour. (2018) (17)
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803 (2016) (17)
Association of CTNNB 1 (-Catenin ) Alterations , Body Mass Index , and Physical Activity With Survival in Patients With Colorectal Cancer (2011) (17)
Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers (2017) (17)
Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance) (2018) (17)
Western-style Diet, pks Island-Carrying Escherichia coli, and Colorectal Cancer: Analyses from Two Large Prospective Cohort Studies. (2022) (17)
Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database (2021) (17)
Heteroduplex formation in SMN gene dosage analysis. (2001) (16)
Biomarker correlation network in colorectal carcinoma by tumor anatomic location (2017) (16)
Intake of Dietary Fruit, Vegetables, and Fiber and Risk of Colorectal Cancer According to Molecular Subtypes: A Pooled Analysis of 9 Studies (2020) (16)
DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility (2020) (16)
Periodontal disease, tooth loss, and risk of oesophageal and gastric adenocarcinoma: a prospective study (2020) (16)
Lifecourse epidemiology and molecular pathological epidemiology. (2015) (16)
Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index (2017) (16)
No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Serrated Polyps in a Randomized Trial. (2020) (16)
Comparison of PCR-RFLP with allele-specific PCR in genetic testing for spinal muscular atrophy. (2003) (16)
Tumor SQSTM1 (p62) expression and T cells in colorectal cancer (2017) (16)
Cytopathology of Oncocytic Carcinoid Tumor of the Lung Mimicking Granular Cell Tumor (2000) (16)
Calcium Intake and Survival after Colorectal Cancer Diagnosis (2018) (15)
Association of Screening Lower Endoscopy With Colorectal Cancer Incidence and Mortality in Adults Older Than 75 Years. (2021) (15)
Vitamin B2 intake and colorectal cancer risk; results from the Nurses' Health Study and the Health Professionals Follow‐Up Study cohort (2016) (15)
Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex! (2013) (15)
Proceedings of the third international molecular pathological epidemiology (MPE) meeting (2016) (15)
Ancient Thali Diet: Gut Microbiota, Immunity, and Health (2018) (15)
Optical Imaging of Mesenchymal Epithelial Transition Factor (MET) for Enhanced Detection and Characterization of Primary and Metastatic Hepatic Tumors (2016) (14)
Tumor Long Interspersed Nucleotide Element-1 (LINE-1) Hypomethylation in Relation to Age of Colorectal Cancer Diagnosis and Prognosis (2021) (14)
Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial. (2019) (14)
Rotating night shift work, sleep, and colorectal adenoma in women (2017) (14)
MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas. (2013) (14)
The competing risks Cox model with auxiliary case covariates under weaker missing-at-random cause of failure (2018) (14)
Challenges and Opportunities in International Molecular Cancer Prevention Research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report (2014) (14)
Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival. (2015) (14)
Comparative effectiveness of N95, surgical or medical, and non‐medical facemasks in protection against respiratory virus infection: A systematic review and network meta‐analysis (2022) (13)
Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance) (2018) (13)
Physical activity during adolescence and risk of colorectal adenoma later in life: results from the Nurses’ Health Study II (2019) (13)
Extensive squamous metaplasia with cytologic atypia in diffuse alveolar damage mimicking squamous cell carcinoma: a report of 2 cases. (2002) (13)
Pre-diagnostic Leukocyte Mitochondrial DNA Copy Number and Colorectal Cancer Risk. (2019) (13)
Bone Morphogenetic Proteins Are Expressed by Both Bone-Forming and Non-Bone-Forming Lesions. (2004) (13)
Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells (2018) (12)
Association of body mass index with colorectal cancer risk by genome-wide variants. (2020) (12)
Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses’ health study and health professionals follow‐up study (2017) (12)
Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology (2017) (12)
Mucosal cancer-associated microbes and anastomotic leakage after resection of colorectal carcinoma. (2019) (12)
A Prospective Study of Smoking and Risk of Synchronous Colorectal Cancers (2017) (12)
Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis (2021) (12)
Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles. (2021) (12)
IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions. (2014) (12)
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science (2022) (11)
LIN 28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans (2015) (11)
Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening (2004) (11)
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer. (2006) (11)
Loss of CDH 1 ( E-cadherin ) expression is associated with infiltrative tumour growth and lymph node metastasis (2016) (11)
Smoking and Incidence of Colorectal Cancer Subclassified by Tumor-Associated Macrophage Infiltrates. (2021) (11)
Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment (2021) (10)
Immunocytochemical detection of insulin-like growth factor II (IGF-II) in choroid plexus papilloma: a possible marker for differential diagnosis. (1999) (10)
Healthy lifestyle, endoscopic screening, and colorectal cancer incidence and mortality in the United States: A nationwide cohort study (2021) (10)
Tumor-Associated Microbiota in Proximal and Distal Colorectal Cancer and Their Relationships With Clinical Outcomes (2021) (10)
MicroRNA MIR 21 ( miR-21 ) and PTGS 2 Expression in Colorectal Cancer and Patient Survival (2016) (10)
Derivation and validation of homocysteine score in u.s. Men and women. (2015) (10)
Twenty-five-year survival of living related kidney transplants: thirty-five years' experience. (2005) (10)
Long‐term status of predicted body fat percentage, body mass index and other anthropometric factors with risk of colorectal carcinoma: Two large prospective cohort studies in the US (2020) (10)
PIK 3 CA Mutation in Colorectal Cancer : Relationship with Genetic and Epigenetic Alterations 1 (2014) (9)
Effects of autologous platelet-rich plasma on the metabolism of human articular chondrocytes (2007) (9)
Practical and Educational Challenges (2007) (9)
Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus (2021) (9)
Correction of Cryptorchidism and Testicular Cancer (2007) (9)
Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance) (2018) (9)
Importance of standard nomenclature for SMN1 small intragenic (“subtle”) mutations (2004) (9)
Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival (2019) (9)
Carrier frequency of spinal muscular atrophy (2008) (9)
Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis (2021) (9)
Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studies. (2019) (9)
Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies (2020) (8)
Plasma sex hormones and risk of conventional and serrated precursors of colorectal cancer in postmenopausal women (2021) (8)
Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk (2019) (8)
Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer (2021) (8)
Post-colonoscopy colorectal cancer: the key role of molecular pathological epidemiology. (2017) (8)
Ogino et Al. Respond to "the 21st century epidemiologist". (2012) (8)
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2022) (8)
Dietary Intake of Branched-Chain Amino Acids and Risk of Colorectal Cancer (2019) (8)
Spatial Organization and Prognostic Significance of NK and NKT-like Cells via Multimarker Analysis of the Colorectal Cancer Microenvironment (2021) (8)
Aspirin, PIK3CA mutation, and colorectal-cancer survival. (2013) (8)
TFF2–CXCR4 Axis Is Associated with BRAF V600E Colon Cancer (2015) (8)
Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes (2020) (7)
Abstract CN06-01: Molecular pathological epidemiology (MPE): Overview of its paradigm and wide applicability even without tumor tissue (2013) (7)
Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer (2015) (7)
KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803. (2016) (7)
Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium (2017) (7)
Improved graft survival in ABO-incompatible living donor kidney transplantation. (2005) (7)
Calcium Intake and Risk of Colorectal Cancer According to Tumor-infiltrating T Cells (2019) (7)
Association of PIK3CA mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma (2021) (7)
Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting (2019) (7)
Periodontal Disease, Tooth Loss, and Risk of Serrated Polyps and Conventional Adenomas (2020) (7)
Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer (2020) (7)
Nut consumption and survival in stage III colon cancer patients: Results from CALGB 89803 (Alliance). (2017) (7)
Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis. (2019) (6)
CDK 8 Expression in 470 Colorectal Cancers in Relation to β-Catenin Activation , Other Molecular Alterations and Patient Survival (2017) (6)
American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance). (2017) (6)
Association Between Smoking and Molecular Subtypes of Colorectal Cancer (2021) (6)
Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer (2022) (6)
Comprehensive molecular characterization of colorectal cancer reveals genomic predictors of immune cell infiltrates. (2015) (6)
Discovery of common and rare genetic risk variants for colorectal cancer (2018) (6)
Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location (2020) (6)
Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps-Gastroenterology (2019) (6)
Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance). (2017) (6)
Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction (2020) (6)
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma (2020) (6)
Calcium intake and colon cancer risk subtypes by tumor molecular characteristics (2019) (5)
A Modified Tumor-Node-Metastasis Classification for Primary Operable Colorectal Cancer (2020) (5)
Immunohistochemical study of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-2 (IGFBP-2) in choroid plexus papilloma. (1999) (5)
Influence of KRAS mutations, persistent organic pollutants, and trace elements on survival from pancreatic ductal adenocarcinoma. (2020) (5)
Functional informed genome‐wide interaction analysis of body mass index, diabetes and colorectal cancer risk (2020) (5)
Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival (2022) (5)
Bayesian Risk Assessment in Genetic Testing for Autosomal Dominant Disorders with Age-Dependent Penetrance (2007) (5)
Dairy intake during adolescence and risk of colorectal adenoma later in life (2021) (5)
IGFBP 3 Promoter Methylation in Colorectal Cancer : Relationship with Microsatellite Instability , CpG Island Methylator Phenotype , and p 531 (2014) (5)
553 Long-Term Risk of Colorectal Cancer Risk After Lower Endoscopy and Polypectomy (2012) (5)
Changes in lifestyle factors after endoscopic screening: a prospective study in the US. (2021) (5)
Plasma metabolomic profiles for colorectal cancer precursors in women (2022) (5)
All Biomedical and Health Science Researchers, Including Laboratory Physicians and Scientists, Need Adequate Education and Training in Study Design and Statistics. (2016) (5)
Association between yogurt consumption and plasma soluble CD14 in two prospective cohorts of US adults (2020) (4)
Plasma Biomarkers of Insulin and the Insulin-like Growth Factor Axis, and Risk of Colorectal Adenoma and Serrated Polyp (2019) (4)
Electronic Health Records and Genomics: Perspectives from the Association for Molecular Pathology Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working Group. (2021) (4)
DNA methylation in breast and colorectal cancers. (2008) (4)
687 – Long-Term Risk of Colorectal Cancer After Removal of Conventional Adenoma and Serrated Polyp: A Prospective Study Within Three US Cohorts (2019) (4)
A Cohort Study of p 27 Localization in Colon Cancer , Body Mass Index , and Patient Survival (2009) (4)
Sugar-sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survival (2021) (4)
282 Aspirin Use and Survival After Diagnosis of Colorectal Cancer (2009) (4)
Correction: Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism. (2019) (4)
Depressed Colorectal Cancer: A New Paradigm in Early Colorectal Cancer (2020) (4)
Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures (2022) (4)
18 q Loss of Heterozygosity in Microsatellite Stable Colorectal Cancer (2007) (4)
Dietary intake of branched‐chain amino acids and survival after colorectal cancer diagnosis (2020) (4)
Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN 1 A expression (2012) (3)
Genome Scale Epigenetic Profiling Reveals Five Distinct Subtypes of Colorectal Cancer (2018) (3)
Coffee Intake of Colorectal Cancer Patients and Prognosis According to Histopathologic Lymphocytic Reaction and T-Cell Infiltrates. (2022) (3)
Preexisting Type 2 Diabetes and Survival among Patients with Colorectal Cancer (2021) (3)
Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1 (2003) (3)
Postdiagnostic dairy products intake and colorectal cancer survival in US males and females. (2021) (3)
Night shift work duration and risk of colorectal cancer according to IRS1 and IRS2 expression. (2018) (3)
Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studies. (2019) (3)
The Sulfur Microbial Diet and Risk of Colorectal Cancer by Molecular Subtypes and Intratumoral Microbial Species in Adult Men (2021) (3)
Aspirin in the era of immunotherapy (2017) (3)
Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer (2022) (3)
Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region. (2022) (3)
Cancer Aspirin Use and Survival After Diagnosis of Colorectal (2010) (3)
Comment on SMN2 deletion in childhood-onset spinal muscular atrophy. (2002) (3)
Body Fatness over the Life Course and Risk of Serrated Polyps and Conventional Adenomas. (2020) (3)
A novel calibration framework for survival analysis when a binary covariate is measured at sparse time points. (2018) (3)
Healthy and unhealthy plant‐based diets in relation to the incidence of colorectal cancer overall and by molecular subtypes (2022) (3)
Body mass index and molecular subtypes of colorectal cancer (2022) (3)
Tumor-associated macrophages and response to 5-flourouracil adjuvant therapy in stage III colorectal cancer (2017) (3)
Plasma Metabolite Profiles of Red Meat, Poultry, and Fish Consumption, and Their Associations with Colorectal Cancer Risk (2022) (3)
Age at Initiation of Lower Gastrointestinal Endoscopy and Colorectal Cancer Risk Among US Women. (2022) (3)
A method to compensate for different amplification efficiencies. (2001) (3)
Abstract 3012: Long-term aspirin use and total and cancer-specific mortality (2017) (3)
Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests (2005) (3)
Abstract IA28: Molecular pathological epidemiology of risk factors and CRC microbial and immune characteristics (2017) (2)
Recurrence of focal glomerulosclerosis in post-renal transplant recipients: report of two cases. (2004) (2)
A prospective study of erythrocyte polyunsaturated fatty acids and risk of colorectal serrated polyps and conventional adenomas (2020) (2)
Ultra-processed food consumption and risk of colorectal cancer precursors: results from three prospective cohorts. (2022) (2)
Multicellular immune hubs and their organization in MMRd and MMRp colorectal cancer (2021) (2)
Coffee Intake and Colorectal Cancer Incidence According to T-Cell Response (2020) (2)
Abstract A24: Lifetime use of antibiotics and risk of colorectal adenoma (2017) (2)
Gene regulatory network analysis identifies sex-linked differences in colon cancer drug metabolism processes (2018) (2)
Response to Li and Hopper. (2021) (2)
Association of colorectal cancer susceptibility variants with tumor subtypes in three large prospective cohorts. (2012) (2)
Night-Shift Work Duration and Risk of Colorectal Cancer According to IRS1 and IRS2 Expression (2019) (2)
826 Post-Colonoscopy Colorectal Cancers Are More Likely to Develop Through the Serrated Pathway of Colorectal Neoplasia (2013) (2)
Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases (2022) (2)
The Burden of Early-Onset Colorectal Cancer and Its Risk Factors from 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019 (2022) (2)
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance) (2021) (2)
Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine (2021) (2)
Colorectal-cancer incidence and mortality after screening. (2013) (2)
Risk prediction models for colorectal cancer: Evaluating the discrimination due to added biomarkers (2021) (1)
Desmoplastic Reaction, Immune Cell Response, and Prognosis in Colorectal Cancer (2022) (1)
Abstract 5221: Linking the molecular profile of colorectal tumors to germline genetic and environmental risk factors (2016) (1)
Reflection on modern methods: causal inference considerations for heterogeneous disease etiology. (2021) (1)
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases (2023) (1)
Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases (2022) (1)
Letter to the Editor (2008) (1)
Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies (2020) (1)
Clinical and Genomic Characterization of Interval Colorectal Cancer in Three Prospective Cohorts. (2022) (1)
Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab (2014) (1)
Physical Activity, Tumor PTGS2 Expression, and Colorectal Cancer Survival: A Molecular Pathological Epidemiology (MPE) Approach (2013) (1)
An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer (2020) (1)
Abstract B03: Dietary patterns during high school and risk of colorectal adenoma in a cohort of middle-aged women (2013) (1)
874 ASSOCIATIONS BETWEEN SCREENING LOWER ENDOSCOPY AND COLORECTAL CANCER INCIDENCE IN YOUNGER ADULTS (2021) (1)
Enrichment of germline DNA-repair gene mutations in patients with colorectal cancer. (2017) (1)
Sugar-sweetened beverage and sugar consumption and colorectal cancer incidence and mortality according to anatomic subsite. (2022) (1)
Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients (2023) (1)
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer (2018) (1)
Dairy intake during adolescence and risk of colorectal adenoma later in life (2021) (1)
Gallstone Disease and Risk of Conventional Adenomas and Serrated Polyps: A Prospective Study (2021) (1)
Microsatellite instability and retrieval of lymph nodes in stage III colon cancer: harbinger or hermit? (2012) (1)
Response to the letter by Lai et al. regarding our manuscript “Statin use and pancreatic cancer risk in two prospective cohort studies” (2020) (1)
Abstract 5129:Fusobacteriumand co-occurring microbes in primary and metastatic colorectal cancer (2018) (1)
Abstract B11: Asthma and risk of colorectal cancer according to tumor immunity and molecular subtypes (2017) (1)
Urinary PGE-MLevels Are Associatedwith Risk of Colorectal Adenomas and Chemopreventive Response to Anti-In fl ammatory Drugs (2014) (1)
Abstract 4837: Tumor microenvironment contributes to RAF-inhibitor resistance through HGF secretion (2012) (1)
Colon cancer-derived oncogenic EGFR G 724 S mutant (2014) (1)
Reply to T. Watanabe et al (2010) (1)
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review (2014) (1)
Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer (2022) (1)
1126 HEALTHY LIFESTYLE, ENDOSCOPIC SCREENING, AND COLORECTAL CANCER INCIDENCE AND MORTALITY: A PROSPECTIVE STUDY IN TWO US COHORTS (2020) (1)
827 Urinary Prostaglandin Metabolites (PGE-M) Are Associated With Risk of Colorectal Adenomas and Chemopreventive Response to Anti-Inflammatory Drugs (2013) (1)
Prediagnostic plasma adiponectin and survival among patients with colorectal cancer. (2015) (1)
The practice of science at its best. (2003) (1)
Smoking and Colorectal Cancer Risk by Tumor Genetic and Epigenetic Subtypes: A Molecular Pathological Epidemiology (MPE) Study (2013) (1)
173PD MicroRNA MIR21, T cells, and PTGS2 expression in Colorectal Cancer (2016) (1)
Cancer classification using the Immunoscore: a worldwide task force (2012) (1)
Adherence to a healthy lifestyle in relation to colorectal cancer incidence and all‐cause mortality after endoscopic polypectomy: A prospective study in three U.S. cohorts (2021) (1)
Association of Fiber Intake with Colorectal Cancer Survival (2017) (1)
IDDF2021-ABS-0085 Association of healthy and unhealthy plant-based diets with the risk of colorectal cancer overall and by molecular subtypes (2021) (1)
Comparative Efficacy of N95, Surgical, Medical, and Non-Medical Facemasks in Protection of Respiratory Virus Infection: A Living Systematic Review and Network Meta-Analysis (2021) (1)
759 Diet and Risk of Colorectal Cancer According to Intratumoral Fusobacterium Nucleatum Levels (2016) (1)
Study of Cyclin D 1 Expression and Prognosis in 602 Colon Cancer Cases (2009) (1)
546 Genome-Wide Gene-Environment Interaction Analysis of Aspirin and Non-Steroidal Anti-Inflammatory Drug Use and Colorectal Cancer Identifies Loci At Chromosomes 12p12.3 and 15q25.2 (2014) (1)
IGF2BP3 (IMP3) expression is a marker of unfavourable prognosis in colorectal cancer (2013) (1)
283 - Obesity is Associated with an Increased Risk of Young-Onset Colorectal Cancer (2018) (1)
Linezolid for Extensively Drug-Resistant Tuberculosis (2013) (1)
Abstract 1418: Marine ω-3 polyunsaturated fatty acid intake and risk of colorectal cancer according to tumor-infiltrating T cells (2016) (1)
Mo1906 Red Meat Is Associated With Risk of Colorectal Cancer, Independent of NAT2 Genetic Background: a Pooled Analysis of 13 Studies (2014) (0)
1006 Circulating 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer (2014) (0)
Association between germline variants and somatic mutations in colorectal cancer (2022) (0)
Abstract 4560: Fusobacterium nucleatum and tumor immunity status according to microsatellite instability in colorectal cancer (2017) (0)
Abstract 4922:KRASandBRAFmutations influence correlation structure of locus-specific CpG island methylation and CIMP in colorectal cancer (2010) (0)
Cytoplasmic localization of p27 (CDKN1B / KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability and CpG island methylator phenotype (CIMP) (2007) (0)
Abstract 684: Body mass index throughout adulthood and incidence of colorectal cancer subclassified by T cell, macrophage, and myeloid cell infiltrates in cancer tissue (2022) (0)
Abstract PR2: Stroma-derived matrix metalloproteinase 9 (MMP9) confers resistance to anti-EGFR therapy through cell-extrinsic activation of ERBB2/ERK/JUN pathway (2012) (0)
Standard Nomenclature: Why Bother? (2015) (0)
Abstract PR002: Development and validation of a risk prediction model for post-polypectomy colorectal cancer in 4 prospective US cohorts (2022) (0)
Old Drug Aspirin as Adjuvant Therapy for Colorectal Cancer : A Promising New Twist for an Related Letters (2009) (0)
Abstract IA019: Molecular pathological epidemiology of tumor microbiota and immunity can give etiologic insights (2022) (0)
USP2a is an oncogenic isopeptidase and a potential target in prostate cancer. (2006) (0)
Sa1671 RISK FACTOR PROFILING OF COLORECTAL CANCER ACROSS REFINED ANATOMIC SUBSITES IN THREE LARGE US COHORTS (2020) (0)
Genome-wide interaction study with smoking for colorectal cancer risk identifies novel genetic loci related to tumor suppression, inflammation and immune response. (2022) (0)
Abstract 630: Smoking is associated with risks of molecular subtypes of colorectal cancer (2019) (0)
Bone morphogenetic proteins are expressed by both bone-forming and non-bone-forming lesions. (2004) (0)
Abstract 5914: Colorectal cancer attributes and outcomes according to Fusobacterium nucleatum enrichment and presence (2023) (0)
Abstract NG03: Marine omega-3 polyunsaturated fatty acid and colorectal cancer prevention and treatment (2017) (0)
Abstract 824: Germline genetic regulation of the adaptive immune response in colorectal cancer (2021) (0)
Tumor-Immune Partitioning and Clustering (TIPC) algorithm reveals distinct signatures of tumor-immune cell interactions within the tumor microenvironment (2020) (0)
Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor‐infiltrating lymphocyte levels (2022) (0)
Bifidobacterium Genus in Colorectal Carcinoma Tissue in relation to Tumor Characteristics and Patient Survival (2018) (0)
Calcium intake and colon cancer risk subtypes by tumor molecular characteristics (2019) (0)
Abstract 1224: Deep targeted tumor sequencing of colorectal cancer cases to study associations of molecular subtypes with clinical, genetic, and lifestyle risk factors (2018) (0)
Sa1932 Prediagnostic Circulating Macrophage Inhibitory Cytokine-1 (MIC-1) Is Associated With Worsened Survival Among Patients With Colorectal Cancer (2015) (0)
Physical activity during adolescence and risk of colorectal adenoma later in life: results from the Nurses’ Health Study II (2019) (0)
Sa1705 Analysis of the Insulin-Like Growth Factor 2 (IGF2) Differentially Methylated Region (DMR) 0 Hypomethylation in Carcinogenesis of Colorectal Serrated Lesions (2013) (0)
734 - Lifestyle Factors and Risk of Serrated Lesion and Conventional Adenoma: A Prospective Study of three US Cohorts (2018) (0)
Intro Pro itating angio cathe appro (2010) (0)
Tumor-Immune Partitioning and Clustering (TIPC): an algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironment (2021) (0)
Mendelian Randomization Causal Analysis Mendelian randomization study of height and risk of colorectal cancer (2015) (0)
Abstract 2300: LIN28 cooperates with Wnt signaling to drive invasive intestinal and colorectal adenocarcinoma in mouse and human (2015) (0)
Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer. (2023) (0)
The competing risks Cox model with and without auxiliary case covariates under weaker or no missing-at-random cause of failure (2016) (0)
Abstract 3297: Prediagnostic circulating concentrations of vitamin D binding protein and survival among colorectal cancer patients (2019) (0)
Sa1967 Post-Diagnosis Folate Intake and Colorectal-Cancer Survival (2013) (0)
631 – Dietary Intake, H2S-Producing Microbes, and Risk of Colorectal Cancer (2019) (0)
1033 Genetic and Epigenetic Features in Synchronous Colorectal Cancer Cases Versus Solitary Cancers, Utilizing 1243 Colorectal Cancer Patients From Two Large Prospective Cohort Studies (2010) (0)
Abstract 4652: Intake of dietary fruit, vegetables, and fiber and risk of colorectal cancer according to molecular subtypes: A pooled analysis (2020) (0)
Tumor Nuclear YAP1 Expression Status and Molecular Characteristics in relation to Immune Response to Colorectal Carcinoma (2018) (0)
826 – Polygenic Risk Score, Family History, and Colorectal Cancer by Molecular Subtypes (2019) (0)
Reply: To PMID 24047059. (2014) (0)
Genetic Predictors of Circulating 25-Hydroxyvitamin D and Prognosis after Colorectal Cancer (2020) (0)
Phase I study of geWtinib, irinotecan, 5-Xuorouracil and leucovorin in patients with metastatic colorectal cancer (2007) (0)
Abstract 159: LINE-1 hypomethylation and patient prognosis in 1118 colorectal cancers (2010) (0)
Abstract 4639: Prognostic significance and molecular associations ofCDKN2A(p16) promoter methylation and loss of expression in colorectal cancer (2010) (0)
777 Aspirin Use and the Risk of Colorectal Cancer Is Modified According to Colonic 15-Prostaglandin Dehydrogenase Expression (2014) (0)
Abstract PR008: Evaluation of intra-tumoral pathogenic bacteria pks+ E. coli, enterotoxigenic B. fragilis and fusobacterium nucleatum in 3695 colorectal cancer cases (2022) (0)
1151 THE SULFUR MICROBIAL DIET SCORE AND RISK COLORECTAL CANCER ACCORDING TO FUSOBACTERIUM NUCLEATUM STATUS AND MOLECULAR SUBTYPES (2020) (0)
Abstract 838: Sugar-sweetened beverage intake and risk of early-onset colorectal cancer (2021) (0)
The Practice of Epidemiology - A Meta-Regression Method for Studying Etiologic Heterogeneity across Disease Subtypes Classified by Multiple Biomarkers (2015) (0)
CDKN1B SINET Ng.2821 (2013) (0)
EFFECT OF DEOXYSPERGUALIN ON LIVING UN-RELATED KIDNEY TRANSPLANTATION (2004) (0)
Abstract 1228: Comparative genomic analysis of young-onset and late-onset colorectal cancer (2018) (0)
Sa598 THE GUT MICROBIOME MODULATES BODY WEIGHT LOSS IN RESPONSE TO PHYSICAL ACTIVITY (2021) (0)
Abstract 2793: Folate, B vitamin and methionine intake and risk of colon cancer in relation toBRAFmutation and CpG Island Methylator Phenotype (CIMP) (2010) (0)
872 – Yogurt Consumption and Risk of Conventional Colorectal Adenoma and Serrated Lesion (2019) (0)
TWENTY FIVE YEARS GRAFT SURVIVAL OF LIVING RELATED KIDNEY TRANSPLANTATION. - THIRTY FIVE YEARS EXPERIENCES- (2004) (0)
Abstract 3039: Evaluation of intra-tumoral pks+ E. coli, enterotoxigenic B. fragilis and Fusobacterium nucleatum, overall and in early onset disease, in colorectal cancer cases (2023) (0)
Tu1812 DEVELOPMENT AND VALIDATION OF RISK PREDICTION MODELS FOR HIGH-RISK SERRATED POLYPS AT SCREENING COLONOSCOPY (2020) (0)
Abstract 2975: The pluripotency factor LIN28 promotes colorectal tumorigenesis and tumor progression (2014) (0)
Abstract 2733: Smoking and colorectal cancer Iincidence by tumor microenvironment in cancer tissue (2021) (0)
Clinical actionability of germline testing in patients with limited colorectal polyps. (2017) (0)
Abstract 5760: Molecular, immune, and microbial profiles of early-onset, intermediate-onset, and later-onset CRCs (2023) (0)
1069 Aspirin Use and Risk of Colorectal Cancer According to Tumor Immunity Status (2016) (0)
The Subtype-Free Average Causal Effect for Heterogeneous Disease Etiology (2022) (0)
Abstract B001: Inverse relationship between tissue fusobacterium nucleatum amount and CD274 (PD-L1) expression of colorectal carcinoma (2022) (0)
Biomarker correlation network in colorectal carcinoma by tumor anatomic location (2017) (0)
Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis (2018) (0)
648 Circulating Macrophage Inhibitory Cytokine-1 (MIC-1) Is Associated With Risk of Colorectal Cancer (2013) (0)
Abstract LB090: Associations of somatically mutated genes and pathways with colorectal cancer specific survival in 4,500 colorectal cancer patients (2021) (0)
Abstract 136: Refining the molecular profile of colorectal tumors to expand prevention and treatment opportunities (2016) (0)
P25 Folate intake and risk of colon cancer in relation to p53 mutational status (2008) (0)
Abstract 2355: Folate and folic acid intake in relation to molecular subtypes of colorectal cancer; a pooled analysis of 7542 cases (2020) (0)
Molecular Pathologic Epidemiology: An Emerging Concept for Integrated Approaches to Cancer Biomarkers (2010) (0)
Abstract B002: History of appendectomy and colorectal cancer oncidence, overall and by intratumoral fusobacterium nucleatum status (2022) (0)
Flavonoid intake and survival after diagnosis of colorectal cancer: A prospective study in two US cohorts. (2023) (0)
751 Identification of a Common Variant With Potential Pleiotropic Effect on Risk of Inflammatory Bowel Disease and Colorectal Cancer (2013) (0)
The practice of science at its best. Commentary (2003) (0)
Genome-Wide Interaction Analysis of Genetic Variants with Menopausal Hormone Therapy for Colorectal Cancer Risk. (2022) (0)
Abstract 1286: Targeted deep sequencing of colorectal tumor tissues to study associations of tumor subtypes with germline genetic, lifestyle, and environmental risk factors (2017) (0)
Abstract 3106: Intestinal mesenchymal fibroblasts promote early epithelial tumorigenesis through activation of integrin beta4 and receptor tyrosine kinases, bypassing common mutational mechanisms (2011) (0)
Abstract 3270: Association of low-carbohydrate diet and macronutrient intake with colorectal cancer survival (2017) (0)
Abstract 3006: Metabolomic signatures of metabolic disturbance and inflammation in relation to colorectal cancer risk (2023) (0)
Smoking and colorectal cancer survival in relation to tumor LINE-1 methylation levels: a prospective cohort study (2022) (0)
Oncogenesis and Colon Exhibit Distinct Patterns of Genome Instability and Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, (2012) (0)
Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2023) (0)
Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts (2018) (0)
Epigenomics: Epigenomic diversity of colorectal cancer (2012) (0)
Abstract 229: Genome-wide association study by colorectal carcinoma subtype (2018) (0)
Derivation and Validation of Homocysteine Score in U . S . Men and Women 1 – 3 (2014) (0)
Periodontal Disease, Tooth Loss, and Risk of Colorectal Adenoma: Results from the Nurses' Health Study (2017) (0)
W1737 Advanced Colorectal Neoplasia is Associated With Telomere Shortening Within the Normal Colorectal Mucosa (2010) (0)
Utility of Continuous Disease Subtyping Systems for Improved Evaluation of Etiologic Heterogeneity (2022) (0)
Whole‐exome sequencing analyses of colorectal cancer with Fusobacterium nucleatum (2017) (0)
The competing risks Cox model with auxiliary case covariates under weaker missing-at-random cause of failure (2017) (0)
Proceedings of the third international molecular pathological epidemiology (MPE) meeting (2017) (0)
Abstract B011: Immunoediting in untreated mismatch repair deficient colorectal cancer (2018) (0)
Abstract 1598: Deep targeted sequencing of colorectal cancer cases to study associations of molecular subtypes with clinical, genetic, and lifestyle risk factors (2019) (0)
Development of dietary methyl score using plasma homocysteine level in the large two US cohort study (2013) (0)
Novel driver genes and genomic predictors of immune infiltrates in colorectal cancer. (2016) (0)
S1935 Cathepsin B Expression and Survival After Diagnosis of Colorectal Cancer (2010) (0)
Abstract LB-249: Marine omega-3 fatty acid supplementation and risk of colorectal adenomas and serrated polyps: A randomized placebo-controlled trial (2019) (0)
Mortality factors in pancreatic surgery: A systematic review. How important is the hospital volume? (2022) (0)
Abstract LB-323: Self-reported sleep duration and subsequent risk of colorectal cancer in two large cohorts of women and men (2012) (0)
MANAGEMENTS AND OUTCOMES OF LIVING KIDNEY GRAFTS WITH MULTIPLE ARTERIES (2004) (0)
573: ASPIRIN USE AND COLORECTAL CANCER INCIDENCE ACCORDING TO LIFESTYLE FACTORS (2022) (0)
The Prevalence and Prognosis of Microsatellite Instability-High/Mismatch Repair-Deficient Colorectal Adenocarcinomas in the United States. (2023) (0)
Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk (2019) (0)
50. Personalized medicine in practice: Comprehensive cytogenomic profiling of a lung adenocarcinoma leads to re-classification of a concurrent lymphoma (2021) (0)
Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting (2019) (0)
Abstract 479:BRAFandKRAS mutation define distinct subtypes of the CpG island methylator phenotype in colorectal cancers (2019) (0)
398: THE GUT MICROBIOME MODULATES BODY WEIGHT RESPONSE TO PHYSICAL ACTIVITY (2022) (0)
Abstract PL05-04: Tumor biomarker discovery for aspirin chemoprevention by molecular pathological epidemiology (MPE) approach (2013) (0)
MALIGNANCIES AFTER RENAL TRANSPLANTATION, A SINGLE CENTER REPORT. (2004) (0)
Multiplexed Immuno‐Profiling of the Colorectal Carcinoma Microenvironment Using Archival Human Tissue (2018) (0)
Genetic Variants in the Regulatory T cell–Related Pathway and Colorectal Cancer Prognosis (2020) (0)
Gastrointestinal , Hepatobiliary and Pancreatic Pathology HIF 1 A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers (2010) (0)
Abstract 876: Long-term use of aspirin and risk of cancer (2015) (0)
631 THE IMPACT OF SCREENING LOWER ENDOSCOPY ON COLORECTAL CANCER INCIDENCE AND MORTALITY ACCORDING TO AGE: WHEN CAN WE DISCONTINUE SCREENING? (2020) (0)
Abstract PR005: Features and susceptibility to dietary-induced alkylating damage in colorectal cancer (2023) (0)
Abstract PR01:Fusobacterium nucleatumand mutational landscape of colorectal cancer in whole-exome sequencing analysis (2017) (0)
116: ASSOCIATION BETWEEN ULTRA-PROCESSED FOOD CONSUMPTION AND RISK OF COLORECTAL CANCER PRECURSORS IN THREE US COHORTS (2022) (0)
Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival (2022) (0)
Endoscopic screening and risk of colorectal cancer according to type 2 diabetes status. (2022) (0)
Imaging , Diagnosis , Prognosis Speci fi c Mutations in KRAS Codons 12 and 13 , and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers (2012) (0)
Reply to letter entitled ‘How dense, how intense? Role of tumour‐infiltrating lymphocytes across colorectal cancer stages’. Re: Nosho et al. Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 2010; 222: 350–366 (2011) (0)
Body Mass Index and Other Anthropomorphic Variables in Relation to Risk of Colorectal Carcinoma Subtypes Classified by Tumor Differentiation Status (2018) (0)
Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival (2023) (0)
884 Aspirin Use, the 8q24 Cancer Susceptibility SNP rs6983267, and Risk of Colorectal Cancer According to CTNNB1 (β-Catenin) Alterations (2012) (0)
Abstract 4205: Colorectal cancer molecular markers and subtypes in relation to disease survival (2018) (0)
Abstract 3019: Density of T cell subsets in colorectal cancer in relation to disease-specific survival (2023) (0)
870 – Plasma Biomarkers of Insulin and the Insulin-Like Growth Factor Axis, and Risk of Colorectal Adenoma and Serrated Polyp: A Prospective Study in US Women (2019) (0)
Tu1417: POST-DIAGNOSTIC MULTIVITAMIN SUPPLEMENT USE AND COLORECTAL CANCER SURVIVAL (2022) (0)
Abstract 4612: Genetic variants in epigenetic pathways and risk of multiple cancer types in the GAME-ON consortium (2015) (0)
Postmenopausal Hormone Therapy Is Primarily Associated with Reduced Risk of Colorectal Cancer Arising through the Adenoma-Carcinoma Pathway (2020) (0)
Effect of CD274 (PD-L1) overexpression on survival outcomes in 10 specific cancers: a systematic review and meta-analysis (2023) (0)
Simple Prediction Model for Colorectal Serrated Polyps: Development and External Validation Study in US Prospective Cohorts. (2023) (0)
Sugar-sweetened beverage and sugar intake during adolescence and risk of colorectal cancer precursors: a large prospective U.S. cohort study (2020) (0)
Abstract 4348: A prospective study of smoking habit and risk of synchronous colorectal cancers (2016) (0)
Su1999 PERIODONTAL DISEASE, TOOTH LOSS AND RISK OF SERRATED POLYPS AND CONVENTIONAL ADENOMAS (2020) (0)
802 EMPIRICAL DIETARY PATTERN ASSOCIATED WITH SHORT-CHAIN FATTY ACID-PRODUCING BACTERIA IN RELATION TO COLORECTAL CANCER RISK (2021) (0)
Abstract A010: Molecular characteristics and prognosis of early-onset colorectal cancer according to detailed anatomical locations: Comparison to later-onset cases (2022) (0)
Proceedings of the second international molecular pathological epidemiology (MPE) meeting (2015) (0)
Abstract 693: Calcium intake and risk of colorectal cancer according to tumor-infiltrating T cells: Results from two large U.S. prospective cohorts (2018) (0)
Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting (2022) (0)
Automatic focusing and automatic exposure control device (1986) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Shuji Ogino?

Shuji Ogino is affiliated with the following schools:

McGill University
Yale University
Sapporo Medical University
University of Siena
Massachusetts General Hospital
Duke University
Sookmyung Women's University
Kyoto University
Harvard University

Shuji Ogino's Academic­Influence.com Rankings

Shuji Ogino's Degrees

Why Is Shuji Ogino Influential?

Shuji Ogino's Published Works

Published Works

What Schools Are Affiliated With Shuji Ogino?

Shuji Ogino's AcademicInfluence.com Rankings